Seller record · Telehealth service

TeleHealth Med

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The home page refers only to licensed US-based compounding pharmacies and 503A pharmacies, and the footer to third-party licensed pharmacies. 2 more criteria also fail; see the table below.

At a glance

TeleHealth MedTelehealth service

4/8criteria passed

Price: Not yet recorded
Sells: compounded GLP-1 injections, compounded sublingual GLP-1
FDA letters: None on file

Visit TeleHealth Med See all eight dispositions

Telehealth service. Passes 4 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A telehealth weight loss platform that connects patients with independent licensed clinicians who prescribe compounded GLP-1 medication as weekly injections or daily under-the-tongue doses after an online health intake, shipped from US compounding pharmacies.

Operating entity Telehealth Med, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	TeleHealth Med's website
S2	Prescription gating	PASS	TeleHealth Med's website
S3	Pharmacy identification	FAIL	TeleHealth Med's website; TeleHealth Med's terms and conditions
S4	Compounding disclosure	PASS	TeleHealth Med's website; TeleHealth Med's GLP-1 instructions page
S5	Analytical documentation	FAIL	TeleHealth Med's website; TeleHealth Med's GLP-1 instructions page; TeleHealth Med's terms and conditions; TeleHealth Med's refund policy
S6	Business address	FAIL	TeleHealth Med's privacy policy; TeleHealth Med's contact page
S7	Price disclosure	NOT VERIFIED	TeleHealth Med's v2 storefront; TeleHealth Med's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed clinician reviews each health intake and either schedules a video consultation or authorizes the prescription, and the answers say all clinicians are licensed, board-certified and based in the United States.Source: TeleHealth Med's website.

S2PASSThe steps list the health intake first and the clinician's assessment second, and the answers say payment is taken only after the pre-qualification assessment is complete and is refunded in full if the clinician finds the patient does not qualify.Source: TeleHealth Med's website.

S3FAILNo filling pharmacy is named. The home page refers only to licensed US-based compounding pharmacies and 503A pharmacies, and the footer to third-party licensed pharmacies.Source: TeleHealth Med's website; TeleHealth Med's terms and conditions.

S4PASSThe home page states twice, beside the GLP-1 product, that the FDA has not approved or evaluated compounded medications for safety, quality or efficacy, and the injection guide describes the medication as a compounded GLP-1.Source: TeleHealth Med's website; TeleHealth Med's GLP-1 instructions page.

S5FAILNo certificate of analysis or lot document is published on the home page, the injection guide, the terms or the refund policy.Source: TeleHealth Med's website; TeleHealth Med's GLP-1 instructions page; TeleHealth Med's terms and conditions; TeleHealth Med's refund policy.

S6FAILThe seller prints two different addresses. The privacy policy opens by placing Telehealth Med, Inc., a Delaware corporation, at 251 Little Falls Drive, Wilmington, DE 19808, while its contact block and the contact page give 1202 Town Park Lane, Ste. 304, Evans, GA 30809.Source: TeleHealth Med's privacy policy; TeleHealth Med's contact page.

S7NOT VERIFIEDA price for the weight loss program did not resolve, because the home page and the legal pages print none, and the weight loss page that the menu and every start button link to loaded blank on every attempt. The check is open.Source: TeleHealth Med's v2 storefront; TeleHealth Med's website.

S8PASSNo FDA warning letter names TeleHealth Med or Telehealth Med, Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded GLP-1 injections, compounded sublingual GLP-1.

Visit TeleHealth Med

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.